Axios @axios
NEW: Eli Lilly is slashing the prices of its most-prescribed insulins amid pressure from consumers and the Biden administration. People with diabetes would see 70% reductions on its most common versions between now and the end of the year. https://t.co/uH2VVfvhAV — PolitiTweet.org